Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 GBX | -2.41% | -10.89% | -71.07% |
Business Summary
Number of employees: 45
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biomarker Research and Development
62.0
%
| 0 | 100.0 % | 0 | 62.0 % | +105.19% |
Proprietary Products
38.0
%
| - | - | 0 | 38.0 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
76.1
%
| 0 | 69.5 % | 0 | 76.1 % | +262.62% |
Rest of World
23.9
%
| 0 | 30.5 % | 0 | 23.9 % | +159.57% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 62 | 07-04-22 | |
Jon Burrows
CEO | Chief Executive Officer | - | 20-03-22 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 17-09-14 |
Thomas Guiel
COO | Chief Operating Officer | - | - |
Bipin Patel
LAW | General Counsel | - | 19-12-31 |
Bartu Ahiska
PRN | Corporate Officer/Principal | - | 19-06-12 |
Ewan Hunter
PRN | Corporate Officer/Principal | - | 11-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Diggle
BRD | Director/Board Member | 60 | 16-10-03 |
David Holbrook
BRD | Director/Board Member | 63 | 19-04-04 |
Jon Burrows
CEO | Chief Executive Officer | - | 20-03-22 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 17-09-14 |
Founder | 62 | 07-04-22 | |
Chairman | 65 | 20-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 311,855,650 | 252,932,158 ( 81.11 %) | 0 | 81.11 % |
Company contact information
Oxford BioDynamics Plc
3140 Rowan Place John Smith Drive
OX4 2WB, Oxford
+44 1865 518 910
http://www.oxfordbiodynamics.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-71.07% | 20.97M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- OBD Stock
- Company Oxford BioDynamics Plc